跳至主要内容
临床试验/NCT00107484
NCT00107484已完成2 期

Phase II Study of Combidex in Axillary Node Staging in Breast Cancer

Virginia Commonwealth University2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2005年9月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
3
试验地点
2
主要终点
Utility of magnetic resonance imaging using ferumoxtran-10 in identifying metastases to axillary lymph nodes

研究概览

简要总结

RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI) using ferumoxtran-10, may help find and diagnose breast cancer that may have spread to the axillary lymph nodes and may help in planning breast cancer treatment.

PURPOSE: This phase II trial is studying how well MRI using ferumoxtran-10 works in finding metastases to the axillary lymph nodes in patients with invasive breast cancer.

详细描述

OBJECTIVES:

Primary

  • Determine the utility of magnetic resonance (MR) imaging using ferumoxtran-10 in identifying metastases to the axillary lymph nodes in patients with invasive breast cancer.

Secondary

  • Determine the changes in MR T1 and T2 signal intensity in primary breast tumors after administration of this drug to these patients.
  • Determine the potential of delayed imaging, in terms of defining tumor boundaries, in these patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Utility of magnetic resonance imaging using ferumoxtran-10 in identifying metastases to axillary lymph nodes

时间窗: 2 years

次要结局

  • Changes in MR T1 and T2 signal intensity(2 years)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验